Outbreak Investigation Task Force
The recent epidemics of Lassa fever in Nigeria, Ebola virus disease in West Africa, MERS-CoV in the Middle East, Yellow Fever in DRC, Angola and Brazil, avian influenza in Asia and Africa and Zika […]
Protein synthesis machinery of Trypanosomatid as a therapeutic target
Pathogenic protozoans of the trypanosomatid group still remain a major world health problem. Cycling between insect vectors and mammalian hosts, Trypanosoma cruzi is the causative agent of Chagas disease, while over 20 Leishmania species […]
Risk of reemergence of urban yellow fever in Brazil: role of the invasive mosquito Aedes albopictus
2016 – 2018 Programmes Transversaux de Recherche Risk of reemergence of urban yellow fever in Brazil: role of the invasive mosquito Aedes albopictus PI: Ricardo Lourenço-de-Oliveira (Instituto de Oswaldo Cruz, Rio de Janeiro, Brazil)
Emergency response to global threats of emerging and re-emerging pathogens
With over 125 years’ experience with infectious diseases, the Institut Pasteur and the Institut Pasteur International Network (IPIN), which is composed of 33 research institutes in 26 countries and five continents, are ideally positioned […]
Brain & Sepsis
Understanding the pathophysiology brain dysfunction during sepsis and the consequences in term of cognitive function.
LeiSHield – A new collaborative action to determine prevalence, anticipate emergence and assess urbanization of cutaneous and visceral leishmaniasis in LeishRIIP partner countries
Protozoan parasites of the genus Leishmania generate severe human diseases termed Leishmaniases. Due to their frequency and the severity of certain clinical forms, these diseases represent a major public health problem and limit the […]
2015HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles, J. Acquir. Immune Defic. Syndr. 2015 Apr;68(4):377-85.
2014Association of single nucleotide polymorphisms in the lens epithelium-derived growth factor (LEDGF/p75) with HIV-1 infection outcomes in Brazilian HIV-1+ individuals, PLoS ONE 2014;9(7):e101780.
2012Temporal dynamics of HIV-1 circulating subtypes in distinct exposure categories in southern Brazil, Virol. J. 2012;9:306.
2012Monitoring the emergence of resistance mutations in patients infected with HIV-1 under salvage therapy with raltegravir in Rio de Janeiro, Brazil: a follow-up study, J. Med. Virol. 2012 Dec;84(12):1869-75.
2011HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories, J. Clin. Virol. 2011 Jul;51(3):186-91.
2011The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages, Blood 2011 Mar;117(10):2944-52.
2009Near full-length genome characterization of HIV type 1 unique BC recombinant forms from Southern Brazil, AIDS Res. Hum. Retroviruses 2009 Dec;25(12):1339-44.
2009Short communication: Evidences of recent decline in the expansion rate of the HIV type 1 subtype C and CRF31_BC epidemics in southern Brazil, AIDS Res. Hum. Retroviruses 2009 Nov;25(11):1065-9.
2009Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil, J. Acquir. Immune Defic. Syndr. 2009 May;51(1):7-12.
2009Genetic characterization of HIV-1 BC recombinants and evolutionary history of the CRF31_BC in Southern Brazil, Infect. Genet. Evol. 2009 Jul;9(4):474-82.
+View full list of publications
Location: Avenida Brasil, 4365 - Manguinhos, Rio de Janeiro - RJ, Brazil